The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.
A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...
The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...
U.S. regulators approved updated COVID-19 vaccines on Thursday ... protection against currently circulating variants,” said ...
The FDA’s approval of the vaccine comes as the federal agency announced approval of both Pfizer’s and Moderna’s updated COVID-19 shots earlier this month, which target the KP.2 strain of the ...
Both Moderna and Pfizer have said they have ample supplies of their updated COVID vaccines on hand, ready for shipment to stores soon after FDA approval. If approved, the Novavax vaccine may take ...
The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The ...
The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...
On August 22, Moderna announced that FDA approved its supplemental Biologics License ... FDA guidance specifying that the preferred composition for the 2024-2025 updated COVID-19 vaccine is a ...
The U.S. Food and Drug Administration (FDA) approved and granted emergency use authorization for updated mRNA COVID-19 ...
The FDA has granted emergency use authorization for a new version of Novavax's COVID-19 vaccine targeting the JN.1 strain.
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 years of ...